Anti-hypertensive medications
reduce stroke risk in people with borderline blood pressure levels
People with prehypertension had a lower risk
of stroke when they took blood pressure-lowering medicines, according
to research reported in Stroke: Journal of the American Heart Association.
Prehypertension is defined as blood pressure ranging between 120/80
mm Hg and 139/89 mm Hg. Hypertension is 140/90 mm Hg or higher.
"Our study pertains to people with pre-hypertensive blood
pressure levels and shows that the excess risk of stroke associated
with these high-normal readings can be altered by taking blood pressure
pills," said Ilke Sipahi, M.D., lead author of the study and
associate director of Heart Failure and Transplantation at the Harrington-McLaughlin
Heart and Vascular Institute in Cleveland, Ohio.
In a meta-analysis of 16 studies, researchers examined data that
compared anti-hypertensive drugs against placebo in 70,664 people
with average baseline blood pressure levels within the pre-hypertensive
range. The researchers found:
- Patients taking blood pressure-lowering medicines had a 22 percent
lower risk of stroke compared to those taking a placebo. This
effect was observed across all classes of anti-hypertensive drugs
studied.
- No significant reduction in the risk of myocardial infarction
occurred, but there was a trend toward lower cardiovascular death
in patients taking blood pressure medications compared to those
on placebo.
- To prevent one stroke in the study population, 169 people had
to be treated with a blood pressure-lowering medication for an
average 4.3 years.
American Heart Association treatment guidelines call for lifestyle
changes, not medications, to reduce blood pressure in people with
prehypertension. Those lifestyle changes include weight loss, physical
activity, a diet rich in fruit and vegetables and low in salt and
fat, and keeping alcohol consumption moderate (no more than two
drinks per day for men and no more than one drink per day for women).
"We do not think that giving blood pressure medicine instead
of implementing the lifestyle changes is the way to go," Sipahi
said.
"However, the clear-cut reduction in the risk of stroke with
blood pressure pills is important and may be complementary to lifestyle
changes."
The cost of long-term therapy and the risks associated with blood
pressure medicines need to be discussed extensively within the medical
community before undertaking guideline changes, Sipahi said.
Co-authors are: Aparna Swaminathan, fourth-year medical student;
Viswanath Natesan, M.D.; Sara M. Debanne, Ph.D.; Daniel I. Simon,
M.D.; and James C. Fang, M.D. Author disclosures are on the manuscript.
|